A new study examined whether routine blood test measures could help in identifying disease flares in people with systemic ...

A new groundbreaking study has recently identified the link between the long-standing mystery in autoimmune disease: Epstein-Barr Virus (EBV) and how it contributes towards the development of systemic ...

The House of Representatives and Senate have both proposed to increase funding for lupus programs that raise awareness of lupus, advance research, and improve care. Therefore, we urge you to contact ...

The physical, emotional and financial toll of lupus can be invisible to those who don’t live with this disease. Lupus symptoms affect each person differently, and it can be difficult for those without ...

With the uncertainty and anxiety that comes from the coronavirus pandemic, it's important that you don't neglect your mental health. In this episode of The Expert Series, Mental Health and Wellness ...

Wondering if you have lupus or receiving a diagnosis of lupus can be challenging and stressful. We have put together some resources to help you find the support and information that you need. Our ...

Sex and intimacy are deeply personal, and lupus can complicate matters. During our recent webinar, Lupus & You: After Dark - A Conversation on Sexual Health and Intimacy, we discussed how lupus can ...

The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...

A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes, which may serve ...

Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...

The Lupus Foundation of America works with medical experts and people with lupus and their care partners to offer clear, easy-to-use educational materials and toolkits to help you navigate every step ...

Fate Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation for the lupus treatment candidate FT819.